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Abstract:  
Pediatric testicular tumors have predominantly favorable histology, which may permit 
testicular sparing surgery (TSS). Limited guidance exists for TSS in adults and is absent in 
pediatric practice.  
The international survey and retrospective case series evaluated the current use of TSS in 
pediatric testicular tumors.  Alongside the complementary literature review the aim of this 
work was to provide evidence that could be used to produce a guideline document.  
Published evidence advocates small mass size as an indicator for TSS, this was not supported 
in the pediatric literature.  Frozen section examination at TSS was not always performed by 
surgeons and yet the literature reports close to 100 % specificity. Tumor markers and 
ultrasound findings are also used as indicators for TSS, a finding reflected in our survey 
results. 
Multiple case series are reported but no large data series exists, which will require 
international collaboration rather than a drive to publish the results of individual centers.  
Common indicators for TSS use; such as tumor markers and imaging are known but further 
work needs to evaluate the role of on-table histology and the risks of this not being 
available. 
Keywords: Testicular-sparing surgery, guidelines, biopsy, consensus, pediatric 
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Introduction  
Testicular tumors are uncommon in the pediatric population representing 1-2 % of all 
children’s tumors. Post-pubertal testicular tumors are likely to be germ cell in origin (GCT), 
however in pre-pubertal males non-GCT are more common [1]. A similar pathological 
separation exists in ovarian tumors and recently there has been a move to perform ovarian-
sparing surgery raising the possibility, in selected male patients with favorable pathology, of 
testicular sparing surgery [2].  
Some guidance exists on use of testicular sparing surgery (TSS) in adult men with a tumor 
size <2cm and a single testis or bilateral tumors comprise the most indications [3–5]. For the 
pediatric population some literature is available, however, there is no consensus [6,7]. The 
aim of this international survey and retrospective case series was to try and evaluate the 
current use of the TSS approach in the management of pediatric testicular tumors and what 
factors determine individual decision-making in specific cases.  A literature review was also 
performed to evaluate the current use of testicular sparing surgery and rationale in the 
pediatric population. 
Materials & Methods  
The Survey Monkey platform was used to create a ten-question survey. The respective link 
was disseminated amongst the members of the ESPU YPUC, the BAPU and the French 
Association of Junior Pediatric Surgeons (ACPF).  Questions were designed to identify 
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indications for choosing TSS and the use of intraoperative frozen section to aid diagnosis. 
Further questions were directed at redo-procedures.  
An online form for patient data collection was created by the JotForm Website 
(www.jotform.com) and this form was sent to respondents of the first survey willing to 
supply patient data (n=31).  The platform used a SSL (secure socket layer) transmission of 
256bit encrypted data and before data analysis, data decryption was performed. 
A comprehensive electronic English-language literature search of PUBMED was conducted 
with the keywords “testicular sparing surgery”, “testis sparing surgery”, “gonad sparing 
surgery”, “human”, “paediatric”, “pediatric”, “child”, “infant” and “adolescent”. Age, 
imaging modalities, serum tumor markers, indication for testicular-sparing surgery, and 
description of the surgical approach, histopathology findings, postoperative treatment 
methods, complications, and long-term outcomes were collected. 
 
Results  
Thirty-eight surgeons responded to the primary survey request from 10 countries and 4 
continents.  Thirty-five (92.1 %) had adopted a testicular-sparing approach in some cases. 
The majority of surgeons (86.84 %) had performed between 1-10 cases and 5.26 % had been 
involved in 11-20, none had performed > 20. Tumor markers were the most important 
factor when deciding to perform TSS 35/38 (92.1 %). Ultrasound was also considered an 
important guide, with 32/38 (84.21 %) stating that this may change their approach. Age of 
the patient was a minor consideration, with 36.84 % never using this as an indication for 
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TSS. Only 23/38 (60.53 %) surgeons used intra-operative histology as part of the decision-
making process with only 5.26 % (n=2) stating that this was because it was no available. In 
terms of outcomes the final histology did not change management. However adverse 
histology resulted in redo-procedures for 5/38 (13.2 %) surgeons and a further 6/38 (15.8 %) 
reported anecdotal cases. 
 The case series, although limited by the number of responses has highlighted some 
important issues which both confirm some of the findings from the survey and raise other 
important areas of variation in practice.  81.58% (31/38) of survey respondents offered to 
contribute to a multi-center case series.  The aim of which was to produce the basis for a 
consensus statement for the use of TSS in managing pediatric testicular masses. 17 cases 
were provided by respondents. However, since the dissemination of the survey four case 
series have been published by individual centers and the major findings are summarized in 
our literature review [8–11]. The 17 cases sent to our encrypted database were provided by 
8 surgeons, from 5 different centers in 3 different countries. Patient mean age was 72.5 
months (± 89.9) with a right-sided predominance 64.7 % (11/17). A painless testicular mass 
was the most common presenting symptom 88.2 % (15/17). Tumor markers were 
performed in 15/17 (88.2 %), ultrasound in 16/17 (94.1 %) again demonstrating both 
ultrasound and tumor markers as being the favored investigations. An inguinal approach 
was performed in 13/17 (76.5 %) with the remaining cases being performed via the scrotum.  
Frozen section histopathology on-table was only performed in 52.9 % (9/17) of the cases; 
none of the cases have required redo-surgery after a mean of 34.1 months follow-up (± 
34.9).  The on-table histology and final histology were comparable in 6/9 cases (66.7 %) with 
the two of the three discrepancies being differentiating between epidermoid cyst and 
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mature cystic teratoma. The final anomaly was in a DSD case presenting with an acute 
inguinal mass whereby on table histology suggested the tissue to be ovarian and final 
histology finding mixed gonadal dysgenesis (table 1). 
 
A total of 152 articles were selected during the first review. Ninety-five did not meet the 
inclusion criteria (3 editorials, 6 including only adult patients, 7 reviews, 15 non-English 
articles and 64 non relevant). Thirty-two case reports and ten small series (N < 5) were also 
excluded. Fifteen studies eventually met the criteria (table 2) including 466 pediatric 
patients of whom 227 (48.7%) had undergone testicular-sparing surgery [8, 9,12–24] with a 
mean follow-up of 69.8 months (14-138). Table 2 summarizes the main findings of this 
review. The time period covered by this review is from 1990 to 2018 with inclusion time 
between 1970 and 2015. The first article about the feasibility of TSS in a large series was 
published by Rushton et al. in 1990 with 5 cases of prepubertal tumors (testicular teratoma) 
[24] and the largest series comes from a multicentric and collaborative study from the 
French Society of Pediatric Surgery published in 2001 [21]. The most common clinical 
presentation was a painless scrotal mass or swelling between 53 and 100% of the cases at a 
mean age of 48.9 months (2 – 210). Indications of TSS in all articles included: prepubertal 
male patients with benign lesions on US and negative serum tumor marker (AFP, B-hCG and 
sometimes LDH). TSS was performed in 16.8 to 100% of the cases depending of the design 
of the studies. Histopathology finding reported teratoma (mature and immature), 
epidermoid cyst, sex-cord cell tumor (Leydig cell tumor, Sertoli cell tumor, and juvenile 
granulosa cell tumor), and benign tumors (simple cyst, hemangioma, lipoma, fibroma, 
hamartoma, splenogonadal lesion, testicular adrenal rest tumors). Two recurrences (0.88%) 
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have been reported for one epidermoid cyst and for one mature teratoma [13,18]. 
Orchiectomy was eventually performed. No case of testicular atrophy has been reported in 
the literature. 
Discussion 
The survey demonstrated that the vast majority of responding surgeons were adopting a 
TSS in some cases. There is a risk of response bias inherent in all surveys and this may be a 
cause for the high rate of TSS uptake in our population.  The individual surgeons’ low case 
numbers, beneath reflecting the rarity of these tumors, might suggest that respondents 
were either early in their careers or this is an approach that is being slowly adopted. 
The importance of adopting an organ sparing strategy clearly lies in the prevention of loss of 
testicular tissue. In adult populations it has been shown convincingly that the preservation 
of testicular tissue is important concerning the long-term outcomes of these patients 
[25,26]. More importantly it has to be an integrative discussion to each treatment decision 
in children and adolescents, especially regarding the potential histology of their tumors [1]. 
 The most valued investigations leading to a surgeon choosing a TSS approach were normal 
tumor markers (92.1 %) and only two of the 17 reported cases did not have tumor markers 
performed (11.8 %).  Tumor markers were frequently combined with USS findings of a 
simple/epidermoid-type cyst (84.2 %) and again in the 17 cases reported to us only 1/17 (5.9 
%) did not have an USS performed. Both tumor markers and ultrasound, which has been 
shown to be particularly reliable in pediatric populations, are accepted as instrumental in 
the work-up for any testicular mass and therefore these results were not particularly 
surprising [16]. 
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One of the controversial aspects highlighted by this work was the choice of a scrotal 
approach over an inguinal approach in some cases.  The oncological theory behind the 
inguinal approach is so that there is optimum control over the venous and lymphatic 
drainage of the potentially malignant lesion to prevent inadvertent spread.  The reason why 
a scrotal approach was used in 4 cases reported to us is not known.  Relevant, available 
literature, reviewed in this manuscript only supports an inguinal approach as a safe 
technique. 
A further unexpected finding was that 23/37 (60.53 %) of the survey respondents reported 
using TSS with no histological diagnosis available at the time of operating. Within the survey 
setting 11/37 (29.7 %) of respondents either personally or anecdotally had performed 
secondary operations to complete treatment in light of the final histology.  In the case series 
a similar percentage of surgeons (52.9 %) were not using on table histology but none 
reported a requirement for redo procedures.  Whether this is again a form of response bias 
i.e. those who had needed to re-operate did not contribute to the case series, is unknown 
but is a possible factor in this discrepancy.  Of those that did perform on-table histology 
there was not a clinically significant difference in the final histology demonstrating 
consistency between the two methods as reported in literature. From the experience in 
adult testicular tumors, however, it is absolutely clear, that frozen section evaluation is a 
key component of effective organ sparing surgery. 
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The first series about TSS was published in 1990 by Rushton et al. [24] who reported 5 cases 
of teratoma without any recurrence. Since then, fourteen articles about TSS in the pediatric 
population with a good reporting of methodology (indication, surgical approach) and 
complete outcomes (age, histopathology, follow-up, recurrence) have been published [8, 
9,12–23]. All of them concluded that in case of selective indications (prepubertal male 
patients, benign lesion on US, negative serum tumor marker), TSS through an inguinal 
approach is a safe procedure. Two (0.88%) cases of recurrence have been reported in the 
literature without any mortality [13,18]. This is the reason why several reviews of the 
literature advocate for the use of TSS in cases of benign lesions in children [7,27–31].  
Most of the prepubertal lesions are benign and the most common pathological finding is 
mature teratoma. Testis-sparing surgery should be performed for these tumors. However, a 
preoperative assessment is mandatory. Serum tumor markers (AFP, hCG and sometimes 
LDH) must be negative according to the age of the child. US is an helpful tool to differentiate 
malignant and benign tumors[16,32]. Scrotal US is highly sensitive for the detection of 
childhood primary intratesticular tumors and, when combined with clinical data, highly 
reliable for differential diagnosis [16,32]. Initial US findings suggestive of a benign lesion 
included a homogeneous or mainly cystic morphology, moderate to good demarcation, 
sometimes with an echogenic rim, normal to increased echogenicity and reduced or normal 
perfusion when compared to the healthy testicular parenchyma. A malignant histology was 
suspected when US showed a rather inhomogeneous, hypoechoic, not well-circumscribed 
lesion, often with increased perfusion and also with diffuse infiltration of the testis, hardly 
leaving any residual normal parenchyma [16]. However, ultrasonography might 
underestimate the amount of normal residual parenchyma because this tissue is 
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compressed against the capsule into a thin rim and therefore should not be used as a factor 
when deciding whether a testis sparing procedure might be appropriate [19].  
The size of the tumor is often discussed to perform a TSS. Size does not matter according to 
Caldwell et al. [8]: they reported 22 TSS to assess for correlation between the tumor size 
and final pathology diagnoses. A 2-cm size cutoff did not accurately predict pathology for 
this cohort, or for just pubertal and post-pubertal patients (p = 0.132, p = 0.154, 
respectively). The present data refute the finding in adults that a 2-cm cutoff accurately 
predicts pathology in pediatric patients with an intratesticular mass and normal STMs.  
Most of the articles highlight the help of frozen section examinations [8,12,16,18,21,30].The 
specificity of a negative frozen section examination is close to 100%. There were no 
contradictions between the definitive histopathological examination and frozen section 
[21]. Frozen section analysis did not miss a TSS inappropriate pathology [8,33]. These data 
suggest that FSE is a valid tool to discriminate between benign and malignant neoplastic 
testicular tumors. However, some authors concluded that it Is not necessary: Patel et al. 
reported seven cases of TTS where frozen section was not performed because preoperative 
laboratory and ultrasonography findings were so characteristic of benign lesions [19].  
Limitations of this study include the relatively low number of respondents; however, 
considering the rare incidence of this pathology, the data at hand seem to provide a valid 
overview over current practice.  
Conclusions  
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Testicular-sparing surgery is being increasingly used in the management of testicular tumors 
in the pediatric population.  Currently there are no guidelines or best practice available.  
Multiple case series exist highlighting success, but no central repository or large data series 
exists, which will require international collaboration rather than a drive to publish the 
results of individual centers.  There are some common aspects being used such as tumor 
markers and imaging, but further work needs to be performed to evaluate the use of on 
table histology and the risks of this not being available. 
 
Key points:  
• Testicular-sparing surgery is becoming an increasingly used approach for managing 
pediatric testicular masses in selected cases 
• Negative tumor markers and favorable ultrasound findings are the most important pre-
operative investigation 
• On table frozen section histology provides a reliable indication of the final histology and 
therefore where available allows TSS to be performed safely. 
• Without on table histology there is an unacceptable risk of a child requiring a further 
operation. 
• Central repository of testicular masses in children required to allow meaningful 
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Table 1:  Summary of the multi-center case series performed by the authors 
 PTM = painless testicular mass 
AIM = acute inguinal mass 
DSD = disorders of sex development 
NS = not sent 
MTC = Mature cystic teratoma 
LCT = Leydig cell tumor 




Frozen section histology Final histopathology 
PTM Scrotal NS Mullerian residues 
PTM Scrotal LCT or benign lesion LCT 
PTM Inguinal NS MCT 
PTM Inguinal Benign lesion Fibrous lesion 
PTM Inguinal Not sent EC 
PTM Inguinal EC MCT 
PTM Inguinal EC MCT 
PTM Inguinal LCT LCT 
PTM Inguinal Testicular parenchyma Testicular parenchyma 
PTM Inguinal NS MCT 
PTM Inguinal NS EC 
DSD + PTM Scrotal NS Testicular parenchyma 
PTM Inguinal NS Lymphoma 
PTM Inguinal NS Lipoblastoma 
PTM Inguinal MCT MCT 
PTM Inguinal EC EC 
DSD + AIM Scrotal Ovarian tissue Mixed gonadal tissue 
Table 1:  Summary of the multi-centre case series performed by the authors (original) 
Indication Operative 
Approach 
Frozen section histology Final histopathology 
PTM Scrotal NS Mullerian residues 
PTM Scrotal LCT or benign lesion LCT 
PTM Inguinal NS MCT 
PTM Inguinal Benign lesion Fibrous lesion 
PTM Inguinal Not sent EC 
PTM Inguinal EC MCT 
PTM Inguinal EC MCT 
PTM Inguinal LCT LCT 
PTM Inguinal Testicular parenchyma Testicular 
parenchyma 
PTM Inguinal NS MCT 
PTM Inguinal NS EC 
DSD + PTM Scrotal NS Testicular 
parenchyma 
PTM Inguinal NS Lymphoma 
PTM Inguinal NS Lipoblastoma 
PTM Inguinal MCT MCT 
PTM Inguinal EC EC 
DSD + AIM Scrotal Ovarian tissue Mixed gonadal 
tissue 
 
Legend:  PTM = painless testicular mass, AIM = acute inguinal mass, DSD = disorders of sex 
development, NS = not sent, MCT= Mature cystic teratoma, LCT = Leydig cell tumor, EC = 
Epidermoid cyst 
 

















































Legend: n = number TSS = testicular-sparing surgery, NS = not specified, EC = epidermoid cyst, JGCT = juvenile granulose cell tumor 
 
Date Study period Author n= 
n= 




scrotal mass Pathology of TSS specimen Recurrence 
Testicular 
atrophy 
2019 2003 -2015 Caldwell 24 22 91.7 128 (1-210) 138 NS NS NS NS 
2018 2005- 2015 Wu 67 30 44.8 18 (3-168) 32 100 % 
63.3 % Teratoma 
26.7 % EC 
3.3 % Leydig cell tumor 
3.3 % Hemangioma 
3.3 % Fibrosarcoma 
0 0 
2017 2001- 2015 Ye 47 16 34 38 (3-141) 56 NS NS 0 NS 
2016 2008- 2015 Friend 12 7 58.3 48 (2.4 - 150) NS NS NS 1 EC (14.2 %) NS 
2015 NS Kao 6 6 100 NS 35 NS 100 % JGCT 0 NS 
2012 1997- 2008 Wang 40 15 37.5 11 (1-144) 50 95.2 % NS 0 0 
2011 1991- 2007 Tallen 5 5 100 74 (6-185) NS 75 % 
40 % Mature Teratoma 
40 % Leydig cell tumor 
20 % EC 
NS NS 
2011 1984- 2008 Bujons 15 11 73 96 (36-156) 67 100 % 
36.3 % EC 
18.2 % Teratoma 
9 % JGCT 
9 % Hemangioma 
9 % Lipoma 
9 % Hamartoma 
9 % Splenogonadal fusion 
0 0 
2010 1987- 2008 Hisamatsu 40 8 20 14 (0.2-128) 68 80 % 63 % Teratoma 37 % EC 
1 Mature Teratoma 
(12.5 %) NS 
2007 2000- 2006 Patel 7 7 100 68 (10-188) 14 NS 
57 % Cystic Teratoma 
29 % EC 
14 % Simple cyst 
0 0 
2004 1976 -2002 Shukla 77 13 16.8 34 (4-120) 72 NS 62 % Mature Teratoma 38 % EC 0 0 
2001 1985 -2000 Valla 83 56 67 NS 58 53 % 
29 % Teratoma 
25 % Cyst 
23 % EC 
9 % Sertoli cell tumor 
7% Leydig cell tumor 
7% Miscellanous 
0 0 
2001 1970- 1999 Ciftci 5 5 100 NS 89 NS 60% Teratoma 40% EC 0 NS 
1999 1967 -1996 Sugita 33 21 63.6 31 (2 - 168) 127 83.8 % 
81 % Teratoma 
9 % Leydig cell tumor 
5 % Sertoli  cell tumor 
5 % Fibroma 
0 0 
1990 NS Rushton 5 5 100 (14 - 78) 96 100 % 80 % Mature Teratoma 20 % Immature Teratoma 0 0 
